Завантаження...

Bacteriofages delivery by courier and delivery service «Nova Poshta». Place orders by phone 0-800-307-407

News

07.02.2021

A phage drug against acne is being prepared for phase II trials

Phase II clinical trials of a topical bacteriophage-based skin care product for acne-prone skin are planned to begin this year.

01.02.2021

Antibiotic resistance in Ukraine according to the results of the AURA study (Part 1)

The medical journal "Health of Ukraine. Surgery, Orthopedics, Traumatology, Intensive Care" No. 4, 2020, published the first part of an article by Professor I. Bereznyakov, dedicated to the state of antibiotic resistance in Ukraine based on the results of the AURA study.

29.01.2021

A synthetic bacteriophage has been created that infects Pseudomonas aeruginosa

Scientists have for the first time manually synthesized bacteriophages with shortened genomes that lyse various strains of Pseudomonas aeruginosa . This experiment could be the first step toward creating new antibacterial agents.

15.01.2021

Bacteriophages restored the bacteria's sensitivity to antibiotics

Antibiotic-resistant Acinetobacter baumannii bacteria became antibiotic-sensitive after exposure to bacteriophages. In an attempt to evade the bacteriophages, the bacteria mutated in a way that made them vulnerable to antibiotics.

10.01.2021

Bacteriophages in agriculture and fisheries

Bacteriophages are currently being explored as a promising means of microbial control in agriculture and fisheries. A special issue of the journal PHAGE: Therapy, Applications, and Research is devoted to this topic.

29.12.2020

Bacteriophages will be tested in the treatment of colorectal cancer

A new method for treating colon and rectal cancer has been proposed based on both natural and GM bacteriophages specific to the pathogenic bacterium Fusobacterium nucleatum .

17.12.2020

Phage therapy for Escherichia coli infection after kidney transplantation

After a kidney transplant, Maria developed an Escherichia coli infection with multiple antibiotic resistance. A two-week course of intravenous phage therapy completely eliminated the pathogen.

08.12.2020

There is no reason for mass prescription of antibiotics to patients with COVID-19

According to data from 24 clinical studies, the proportion of patients with COVID-19 and bacterial infections was 6.9%. Of these, 71.9% received antibiotics.

01.12.2020

FDA approves the use of bacteriophages in patients with COVID-19

The US Food and Drug Administration (FDA) has approved the use of bacteriophages in critically ill COVID-19 patients with secondary bacterial infections that are multiply resistant to antibiotics.

24.11.2020

We invite you to the conference "Modern trends in wound surgery"

Dear colleagues, We invite you to the 20th International Scientific and Practical Conference "Modern Trends in Wound Surgery" on November 26-27, 2020. One of the topics of discussion will be the potential use of bacteriophages in the treatment of chronic ulcers.

24.11.2020

We invite you to the congress “Current issues in pediatric gastroenterology”

Dear colleagues, we invite you to the 5th Scientific Congress with international participation, "Current Issues in Pediatric Gastroenterology," on November 26-27, 2020. Participants will receive a certificate worth 25 BPR points.

17.11.2020

Antibiotic therapy in the first two years of life is a risk factor for many chronic diseases

Children who received at least one course of antibiotics during the first two years of life have an increased risk of developing allergies, celiac disease, obesity, and attention deficit hyperactivity disorder.

31.10.2020

Endolysins from bacteriophages can be included in L'Oréal cosmetics

Due to their unique properties, namely the ability to target bacteria with high specificity, bacteriophage endolysins can be incorporated into innovative skin care products.

23.10.2020

Happy World Bacteriophage Day!

October 22 is World Bacteriophage Day, which kicks off World Bacteriophage Week, which runs until October 28. Congratulations to everyone interested and involved!

15.10.2020

The new book “Bacteriophages: biology, technology, therapy” has appeared in the public domain

Springer has released the textbook "Bacteriophages: Biology, Technology, Therapy" (English). All sections of the book are now freely available.

06.10.2020

Endolysins of bacteriophages against atopic dermatitis

Patient enrollment is open for phase I/IIa clinical trials to evaluate the efficacy and safety of topical application of a drug based on bacteriophage Endolysins for the treatment of atopic dermatitis.

27.09.2020

Native phage therapy: controlled induction of prophages as a weapon against pathogenic bacteria

The new treatment method does not involve introducing any phages into the human body, but it is designed to “awaken” lysogenic phages, which are usually present in any bacteria in the form of prophages.

18.09.2020

Antibiotic therapy increases the risk of inflammatory bowel disease

A comparison of the history of antibiotic therapy in individuals with and without inflammatory bowel disease showed that the risk of developing this chronic pathology increases significantly due to systemic use of antibiotics.